2008
DOI: 10.1007/s12018-008-9015-5
|View full text |Cite
|
Sign up to set email alerts
|

Skeletal Microdamage: Less About Biomechanics and More About Remodeling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
19
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 38 publications
(20 citation statements)
references
References 54 publications
1
19
0
Order By: Relevance
“…The potential detrimental role of accumulated damage due to aging and long-term administration of anti-resorptive drugs remains a clinical concern (Allen and Burr 2008). Quantification of the relative roles of damage, density, and architecture are needed to determine the balance between the positive effects of these treatments on density and architecture (Black et al 1996; Fogelman et al 2000; Reid et al 2002; Dufresne et al 2003; Recker et al 2004) vs. the detrimental effects of accumulated microdamage (Mashiba et al 2000; Mashiba et al 2001b) and bone loss due to aging.…”
Section: Discussionmentioning
confidence: 99%
“…The potential detrimental role of accumulated damage due to aging and long-term administration of anti-resorptive drugs remains a clinical concern (Allen and Burr 2008). Quantification of the relative roles of damage, density, and architecture are needed to determine the balance between the positive effects of these treatments on density and architecture (Black et al 1996; Fogelman et al 2000; Reid et al 2002; Dufresne et al 2003; Recker et al 2004) vs. the detrimental effects of accumulated microdamage (Mashiba et al 2000; Mashiba et al 2001b) and bone loss due to aging.…”
Section: Discussionmentioning
confidence: 99%
“…It is now well established in animal models that the suppression of remodeling allows microdamage accumulation [36,[50][51][52], and that this is not necessarily a BP-specific effect [53].…”
Section: Bps and Microdamage -What We Know (Table 2)mentioning
confidence: 99%
“…In clinical trials, typically of a duration of less than 5 yr, antiresorptives decrease the risk of classical osteoporotic fractures, but it is unclear whether retention of old, less mechanically competent bone tissue could affect mechanical properties in the long term (2)(3)(4). In some cases, atypical fractures were seen in patients treated for less than 2 yr and thus well within the duration of the original phase III trials (5)(6)(7).…”
mentioning
confidence: 99%